Medical-equipment maker Medtronic (NYSE: MDT) recently reported respectable third-quarter earnings, despite our ailing economy. Sales of cardiac rhythm disease management devices, including pacemakers and implantable cardioverter defibrillators (ICDs), fell 4 percent. The division is still suffering from the fallout of a 2007 recall of one of its ICDs, which helped competitors Boston Scientific and St. Jude Medical grab market share last year.
Copyright PHILY - Philly.com
